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Abstract
Background: With effective treatment strategies, the focus of tuberculosis (TB) management has shifted
from the prevention of mortality to the avoidance of morbidity. As such, there should be an increased
focus on quality of life (QoL) experienced by individuals being treated for TB. The objective of our study
was to identify areas of QoL that are affected by active TB using focus groups and individual interviews.
Methods: English, Cantonese, and Punjabi-speaking subjects with active TB who were receiving treatment
were eligible for recruitment into the study. Gender-based focus group sessions were conducted for the
inner city participants but individual interviews were conducted for those who came to the main TB clinic
or were hospitalized. Facilitators used open-ended questions and participants were asked to discuss their
experiences of being diagnosed with tuberculosis, what impact it had on their lives, issues around
adherence to anti-TB medications and information pertaining to their experience with side effects to these
medications. All data were audio-recorded, transcribed verbatim, and analyzed using constant comparative
analysis.
Results: 39 patients with active TB participated. The mean age was 46.2 years (SD 18.4) and 62% were
male. Most were Canadian-born being either Caucasian or Aboriginal. Four themes emerged from the
focus groups and interviews. The first describes issues related to the diagnosis of tuberculosis and sub-
themes were identified as 'symptoms', 'health care provision', and 'emotional impact'. The second theme
discusses TB medication factors and the sub-themes identified were 'adverse effects', 'ease of
administration', and 'adherence'. The third theme describes social support and functioning issues for the
individuals with TB. The fourth theme describes health behavior issues for the individuals with TB and the
identified sub-themes were "behavior modification" and "TB knowledge."
Conclusion: Despite the ability to cure TB, there remains a significant impact on QOL. Since much
attention is spent on preventative or curative mechanisms, the impact of this condition on QoL is often
not considered. Attention to the issues experienced by patients being treated for TB may optimize
adherence and treatment success.
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Introduction
Globally, tuberculosis (TB) is a major public health prob-
lem [1]. In 1997, the World Health Organization (WHO)
estimated that 32% of the world's population was
infected with Mycobacterium tuberculosis [2]. Tuberculosis
was a major cause of morbidity and mortality in Canada
early in the 20th Century. However, with the introduction
of anti-tuberculosis medications in the 1940's and 1950's,
the incidence of TB disease declined significantly [3].
However, after decades of continuous decline in TB rates,
it has reached a plateau of 6 per 100,000 population, cor-
responding to about 2000 cases per year [3,4]. Although
this rate of TB disease within Canada in global terms is rel-
atively low, within special high-risk groups, rates exceed
those seen in many developing countries. In particular,
high rates are seen among Aboriginal persons – both on
and off reserve as well as among the foreign born and mar-
ginalized inner city populations, especially injection drug
users [5-8].
With the development of effective treatment strategies, the
focus of TB management has shifted from the prevention
of mortality to the avoidance of morbidity. As such, there
is increased interest in the quality of life (QoL) experi-
enced by individuals being treated for TB [9]. There are
numerous aspects of active TB that may lead to a reduc-
tion in QoL. Treatment of active TB requires prolonged
therapy (at least 6 months) with multiple, potentially
toxic drugs that can lead to adverse reactions in a signifi-
cant number of patients [10,11]. Also, among foreign
born patients, there is considerable social stigma associ-
ated with active TB leaving the individual feeling shunned
and isolated from their friends and families [12-14].
Finally, among Aboriginal and marginalized inner city
populations, there is a lack of knowledge regarding the
disease process and its treatment which may contribute to
feelings of helplessness and anxiety [15-17].
Few studies have examined quality of life in patients with
active TB [18,19]. While these studies determined specific
decrements in the QoL in these patients, none have
included the mixture of patients (marginalized and for-
eign born) treated within Canada. Therefore, the objective
of our study was to identify areas of QoL that are affected
by active TB infection using focus groups and individual
interviews [20,21].
Methods
Design and Setting
This was a multi-site study involving three TB Centres in
Vancouver, British Columbia. Patients were recruited
from the TB Clinic at the BC Centre for Disease Control,
Willow Chest Pavilion at Vancouver General Hospital and
the Downtown TB Clinic. All these clinics are part of the
Vancouver Coastal Health Authority. Ethics approval was
obtained from the University of British Columbia Behav-
ioural Research Ethics Board and each subject provided
signed, informed consent to participate in the study.
Subjects
Subjects with active TB who were receiving treatment were
eligible for recruitment into the study. Subjects who were
less than or equal to 16 years of age and who did not speak
English, Cantonese or Punjabi were excluded (interpreters
for non-English language participants who spoke these
languages were available).
Procedures
The initial contact was be made by the study nurse at the
individual clinics. For those individuals residing in the
inner-city region of Vancouver, gender-specific focus
groups were planned with 6–8 participants who had
active TB. Each participant was reimbursed $25 for their
time. Focus group discussions are a variation of interviews
designed for the purpose of gathering data about a specific
topic from a group of individuals. Each focus group was
led by an experienced facilitator.
For participants who came to the TB Clinic at the BC Cen-
tre for Disease Control (and those who were hospital-
ized), individual interview sessions were conducted
assessing similar information as obtained in the focus
groups. The reason for using individual interviews rather
than the focus group approach was two-fold. Firstly, as
these individuals often had other commitments (such as
work or family care), assessments needed to be done at
the time of their appointments and could not be specially
scheduled. Secondly, due to the cultural backgrounds,
most of these participants did not wish to participate in a
group setting in which details of their disease and their
feelings were explored. Each interview was conducted by
an experienced interviewer in combination, when neces-
sary, with an interpreter fluent in Cantonese or Punjabi.
Specifically, in either the focus group or interview setting,
the facilitator began the session with an open-ended,
standard question that began all sessions (e.g. "how did
you find out you had TB?"). Using open-ended, probing
questions, participants were asked to discuss their experi-
ences of being diagnosed with tuberculosis, what impact
it had on their lives, issues around adherence to anti-TB
medications and information pertaining to their experi-
ence with side effects to these medications. Each partici-
pant was invited to comment on each question and
provide their perspective on the content area. At the end
of each session, the facilitator summarized salient points
that arose during the discussion and invited further com-
ments and discussion around these points and confirmed
agreement.Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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Data collection and analysis
For all participants, data obtained were audio-recorded,
transcribed verbatim, and analyzed. For participants who
spoke Cantonese or Punjabi, field notes were kept by the
nurse facilitators who are fluent in those languages.
Constant comparative analysis was used as a method to
explore and identify patterns and themes that emerged
from the data [21]. Various strategies were used to system-
atically monitor the validity and reliability of the data. Data
were analyzed by two individuals experienced with qualita-
tive data and consensus validation was used to confirm cat-
egories and the matching of transcribed quotes with
categories derived from the analysis. Categories and tran-
script matching were then reviewed by the focus group
facilitator to further ensure that the categories made sense
and represented the data they contain. The categories were
then collapsed and analyzed for emergent themes.
Results
We conducted two focus group sessions, one with seven
male participants and another six female participants; the
rest of the participants for the study underwent individual
interviews, including 4 hospitalized patients. In total, 39
persons with active TB participated in the study. The
demographics of the study participants are described in
Table 1. The mean age was 46.2 years (SD 18.4) and 62%
were male. Most of the participants were Canadian-born,
either white or Aboriginal, while 38% were foreign-born
from South-East Asia, South Asia, Latin America and
Africa. The majority of participants were interviewed in
English (69%) and the rest required either a Cantonese
(18%) or Punjabi (13%) translator. For the majority of
patients, concurrent illnesses included HIV, Hepatitis B or
C. Thirty-six percent of patients drank alcohol or used
illicit drugs on a daily basis. The majority of patients was
unemployed with an annual income of ≤$15,999 and a
mean level of education of 9.2 years of school (SD 3.1).
Analysis identified four main themes comprising medica-
tion related issues, diagnosis, social support and knowl-
edge of TB. The following text provides a summary of the
content of the themes with illustrative quotes in Table 2
and 3.
Theme 1: Diagnosis issues
This theme describes issues related to the diagnosis of
tuberculosis (Figure 1). Sub-themes were identified as
'symptoms', 'health care provision', and 'emotional
impact'.
Symptoms
Thirty-five quotes pertained to symptoms experienced by
the participants at the time of diagnosis. Of these, 19 were
related to specific symptoms whereas 16 participants
expressed the view that they were asymptomatic at the
time of being diagnosed. The most common symptoms
experienced by the respondents were cough (n = 13),
fatigue/weakness (n = 5), fever/night sweats (n = 5) and
shortness of breath (n = 4). Most patients sought medical
attention due to cough or "pneumonia-like" symptoms
and feelings of general malaise. For example, one patient
stated "I was coughing up harsh yellow stuff"; while
another stated "I started to feel real tired and had a cold
that just wouldn't go away".
Table 1: Patient Characteristics
Participants (N = 39)
Mean age, yrs (SD) 46.2 (18.4)
Males, N (%) 24 (62)
Foreign-born, N (%) 15 (38)
Region of origin, N (%)
Canadian – Caucasian 10 (26)
Canadian – Aboriginal 14 (36)
India/Pakistan 5 (13)
South East Asia 8 (21)
South America 1 (2)
Africa 1 (2)
Language used during interview, N (%)
English 27 (69)
Cantonese 7 (18)
Punjabi 5 (13)
Interview/focus group session conducted, N (%)
Outpatient clinic 35 (89)
Hospitalized 4 (11)
Concurrent illness, N (%)
HIV-positive 12 (31)
Hepatitis B or C 12 (31)
Diabetes mellitus 5 (13)
Cardiovascular disease 3 (8)
Cancer 3 (8)
Epilepsy 1 (2)
Alcohol or recreational drug use, N (%)
Alcohol 8 (21)
Drugs 6 (15)
Employment status, N (%)
Full-time 4 (11)
Part-time 5 (13)
Unemployed 20 (50)
Retired 10 (26)
Income
≤$15,999 35 (89)
$16,000 – $39,999 1 (2)
$40,000 – $49,999 1 (2)
≥$50,000 1 (2)
Years of education, mean (SD) 9.2 (3.1)
Marital status, N (%)
Single 14 (38)
Married 11 (28)
Common-law 5 (13)
Divorced 8 (21)Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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Four patients expressed that they were "unsure" how they
acquired TB. For example, a woman stated "I didn't even
know I had it. I was surprised 'cause I felt real good".
Other illustrative quotes are shown in Table 2.
Health care provision
Most comments, related to the provision of health care at
or around the time of diagnosis, were related to commu-
nity health care providers and their initial hospitalization.
Many patients expressed frustration with the health care
system at their time of diagnosis due to lack of provider
knowledge with respect to tuberculosis. Many patients
either felt that they had a delayed diagnosis or delayed
treatment due to issues related to their health care pro-
vider. For example, on male patient stated, "Family physi-
cians should know more about this disease...where to
refer patients to. This is an old disease". Another patient
said, "Although my GP gave me a diagnosis, he told me to
wait for treatment. We were concerned and phoned the
British Columbia Lung Association who referred us to the
TB clinic". Another stated, "I contracted a flu-type infec-
tion with fever. My GP said go home and take Tylenol but
my symptoms continued so I went to see the locum who
told me to take Advil. Then I started non-stop coughing. I
asked my GP to get an X-ray but he flatly refused."
Many participants reported negative experiences with
their initial hospitalization after being diagnosed with TB.
Specifically, they stated feelings of isolation, rejection and
boredom (Table 2). No participant gave a positive report
about the initial hospitalization experience however one
30 year old male participant stated "I had no negative feel-
ings about my hospital stay but it hurt my financial situa-
tion...but I knew I had to be there. There are laws against
TB."
Table 2: Selected Illustrative Quotes for Theme 1: Diagnosis Issues for TB
Theme 1: Diagnosis Issues
Sub-Theme: Symptoms
Coughing
"I felt tired all the time and had a cough that just wouldn't go away". (Female)
"I had a really bad cough for 3 months and then I started coughing up blood. This made me scared so I went to the doctor". (Male)
Fatigue/weakness
"I just felt tired all the time. I did not have the energy to do anything". (Male)
"I had fatigue and a continuous cough for 6 months. I thought I had persistent flu but then after a while the symptoms got so bad that I went to 
see a doctor". (Male)
Fever/nightsweats
"I had a fever and chest pain for 1 month; I thought this was pneumonia so I went to see my family doctor". (Male)
"I had night sweats for several months and a fever so after a while I went to see my doctor". (Male)
Asymptomatic
"I did not know I had TB, I was really surprised because I felt really good". (Male)
"I had a general examination and that's when I found out I had TB, otherwise I had no symptoms" (Female)
Sub-Theme: Health Care Provision
Delayed Diagnosis
"I had a friend who was sick with TB in the hospital. I asked my GP to get tested but he did not feel I needed to. Anyway, I was negative but I 
knew something was wrong so I asked for a chest X-ray. He did not agree at the beginning but finally he did and that's when I found that I had 
TB". (Female)
Hospitalization
"I came out of a coma from meningitis and that's when they told me I had TB. They threw me in a TB ward at VGH which was worse then a 
prison. I didn't like the restrictiveness so I took off...the isolation was too much". (Male)
"The only thing to do at the hospital was to eat and sleep. There are no programs there and you are confined in one area". (Male)
"Everyone wears gloves and masks to come and see you, you feel like a leper". (Male)
Sub-Theme: Emotional Impact
Calm, Accepting, or Apathetic
"I was okay about it. I knew people who had this before and so I knew I would be in the hospital for a while but then after taking medicines I 
would be fine". (Male)
"I felt calm and confident in the medical profession". (Male)
Scared, or Afraid
"I was scared of dying. My Grandma had it and she was in the sanitorium before she died of it". (Female)
Shocked/Surprised, or Devastated
"I was shocked. It was such a surprise because I was working full-time as a nurse in India before immigrating here and I was healthy". (Female)
"I was devastated because I had another illness. I didn't feel that I deserved it". (Female)
Worried/Concerned or Depressed
"I was worried about passing it on to other people". (Male)
"I was depressed because I had a daughter whom I could not see while in hospital". (Female)Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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Table 3: Selected Illustrative Quotes for Theme 2: Medication Issues for TB
Theme 2: Medication Issues
Sub-Theme: Adverse Events
Gastrointestinal Disturbances
"I had lots of vomiting after I started taking the pills and didn't have any appetite". (Male)
"I have to eat before I take my pills, if I don't then I feel sick and my stomach hurts". (Male)
Itchiness
"I felt itchy all over and was told to take benedryl but that made me really sleepy". (Male)
"I had lots of itchiness when I first started taking the pills but it is better now and I put lotion on my skin". (Female)
"I was so itchy with one of the pills that I could not sleep all night long for days". (Female)
Sub-Theme: Ease of Administration
Size of Medication
"I felt physically sick because of the size of the pills; they are too big". (Female)
"The pills are so big, it is hard to swallow them". (Female)
"I feel nauseated when I take the pills because they are so large". (Male)
"I can't swallow those white pills; I need to crush then otherwise I vomit it back up". (Female)
Number of Medications
"I thought that many tablets a day ...it is not possible to take on an empty stomach". (Male)
" There were too many pills to take at once, especially at the beginning but now it is much better with just six to take in a day". (Female)
Sub-Theme: Compliance
Clinic-based patients
"I was taking other pills so it was easy to take the TB medications too". (Female)
"I did not forget to take my pills because I want to get better". (Female)
"I understand the importance of taking the tablets so I do not forget; I take them in the mornings, half-hour before my breakfast". (Male)
"I place it in my container the night before so that I remember to take it the next day". (Male)
Inner-city Patients
"I always take my pills since I get them with my methadone everyday". (Female)
"The [street] nurse always finds us and gives me the medications". (Male)
"If I've been drinking too much then sometimes I don't know what the time is". (Male)
"If I'm picking empty cans and bottles on the other side of town, it's hard to get to [street nurse name] to get my pills every day". (Male)
"I missed taking some pills because I was drunk or high on drugs". (Female)
Main themes and sub-themes related to tuberculosis as identified through transcribed focus groups Figure 1
Main themes and sub-themes related to tuberculosis as identified through transcribed focus groups
Tuberculosis Related Issues
Diagnosis Medication Social Support Health Behavior
Adverse Events Ease of Administration Behavior Modification TB Knowledge Friends and Family Adherence Symptoms Health Care
Provision
Emotional Impact
ORIGINAL TRANSCRIPTION OF FOCUS GROUPSHealth and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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Emotional impact
Thirty-five quotes pertained to emotions experienced by
the participants at the time of diagnosis. Of these, patients
expressed a wide range of emotions from being calm,
accepting or apathetic (n = 11), scared or afraid (n = 7),
shocked or surprised (n = 6), "devastated" (n = 4), worried
or concerned (n = 4), and depressed (n = 3). Representa-
tive quotes for these emotions are presented in Table 2.
Of the individuals expressing apathy or calmness related
to the diagnosis, many expressed that TB was just another
disease to contend with on top of other chronic condi-
tions. For example, one patient stated "Well, it is like HIV.
It is in my system. What can you do?" Another person
with terminal cancer stated "I had no reaction to the diag-
nosis. I am more concerned with the spread of my cancer
and that I don't have long to live anyhow".
Of those expressing concern, there were two distinct rea-
sons cited for this emotion: 1) concern for themselves as
they knew relatives or friends who had previously been
infected with TB and had experience prolonged hospitali-
zation or death; and 2) concern for others in terms of
passing the disease on to family and friends. For example,
a male patient said "I was kind of scared because the only
person I knew who had TB died of it. Also, I was worried
about other people catching it from me". Another woman
stated "I was scared. It is like an old disease and I know
when you have it, it is not very nice to have it, especially
because I have a seven month old baby."
The individuals who expressed shock and surprise at the
diagnosis attributed these emotions to their lack of symp-
toms. As such, they had not expected a diagnosis such as
TB when they have visited their health care provider
despite having other diseases such as HIV (see Table 2).
Theme 2: Medication issues
This theme discusses the most important factors with
respect to medications for the treatment of TB. (Figure 1).
As such, the sub-themes identified were "adverse effects",
"ease of administration", and "adherence".
Adverse events
There were thirty-nine comments related to adverse events
experienced by taking the medications. Most of these were
related to specific symptoms that were thought to be
related to taking specific drug therapies. The most com-
mon complaints were related to gastrointestinal
disturbances (nausea, vomiting and diarrhea) and
itchiness due to isoniazid. Despite having adverse events,
patients stated that they continued to take their
medications. For example, one female patient said, "There
is nothing you can do. You have to just continue". Repre-
sentative quotes from these participants are included in
Table 3.
Ease of administration
Most comments related to the dose and dosing schedule
pertained to the size (n = 3) and number of tablets/cap-
sules (n = 7). For example, patients felt that the large size
of some of the dosage forms (such as ethambutol and
rifampin) led to gagging and vomiting. In addition, many
patients expressed consternation at the number of pills
that they had to take with each dose. For example, one
patient said, "When I looked at ten tablets, I thought, on
an empty stomach, I cannot". Representative quotes from
these participants are included in Table 3.
Compliance
Individuals living in the inner city of Vancouver,
expressed little concern for compliance-related issues as
they either picked up the anti-TB medications with their
methadone or the Street-Nurses would find them daily to
administer the medications. As an example, one patient
stated "It comes with my methadone. When I get that, I get
my TB pills". Another stated, "I never worry about it. I
know [the Street Nurse's name] will bring it to me". How-
ever, despite high compliance in these patients, several
identified alcohol (n = 13) or other illicit drug use (n = 8)
as being the reason why they had missed doses.
Those who came to the TB treatment clinic expressed high
compliance due to the perceived gravity of the diagnosis.
For example, one woman patient stated, "It is easy to
remember because it is at the fore-front of mind. I want to
get rid of it". Another person attributed compliance to the
law: "I never forget to take my pills because I don't want
to go to jail". Representative quotes from these partici-
pants are included in Table 3.
Theme 3: Social support and functioning
This theme describes social support and functioning
issues for the individuals with TB (Figure 1). Specifically,
the impact on their relationships with family, friends and
peers was affected by TB. In addition, social functioning
was impacted through the ability to interact with friends
and family as well as engaging in social and leisure
pursuits.
Most participants expressed that their family and friends
were aware of their TB diagnosis (n = 18), while 11 stated
that only their friends knew and 10 stated that only their
immediate family knew. Of those who stated that only
their friends were aware of their diagnosis, most of these
persons residing in the inner city noted that they did not
have family with whom they communicated. Representa-
tive quotes from these participants are included in Table
4.Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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However, one individual stated that she was "secretive
because other people will feel that I am contagious".
Another male participant stated a reluctance to tell his
friends because "I do not want go cause mass hysteria". A
school-age boy did not tell his friends out of fear of being
shunned. In addition, he missed eight weeks of school
and had to retake several courses. In one instance, fear of
being shunned in a Punjabi speaking participant was
instilled by the treating physician ("I was told by Dr. [phy-
sician's name] that if my community knew, it would
empty out the hall [referring to the religious prayer hall]".
Another reported that his family "told me not to take my
pills anymore because they make me sick" despite being
very supportive and understanding regarding the diagno-
sis. A Cantonese-speaking male stated that "I will be hap-
pier once I am cured. Then, I can go out to restaurants and
public places again."
There were 39 comments related to the reactions of
friends and/or family members to the participants' diag-
nosis of TB. Of these, most could be categorized as sup-
portive or concerned (n = 21), although others had
negative feelings such as fear (n = 7), shock or disbelief (n
= 8), and anger (n = 3). One participant stated "my mom
was really concerned but my friends did not believe
it...they encouraged me to get the right diagnosis".
Another stated that her partner had increased his reading
on TB and was receiving regular skin tests although her
mother and brother would not talk about the TB diagnosis
or the clinic visits. Another stated that since his partner
was not understanding about modifying his lifestyle, he
was forced to end the relationship with her and move out.
Representative quotes from these participants are
included in Table 4.
Theme 4: Health behavior
This theme describes health behavior issues for the indi-
viduals with TB (Figure 1). Sub-themes were identified as
"behavior modification" and "TB knowledge."
Table 4: Selected Illustrative Quotes for Theme 3 and 4: Social Support and Health Behavior Issues for TB
Theme 3: Social Support and Functioning
Sub-Theme: Social Support
Clinic-based patients
"My family knows and they comforted me so I felt much better". (Male)
"My wife was calm about it and this gave me support". (Male)
"Mom was concerned for me since her grandmother had died of TB". (Female)
Inner-city Patients
"My friends stayed away when they found out, they thought I was contagious. I tried to tell them but still I did not see them again". (Male)
"My friends do no want to hang around me. It's the fear of the unknown...they just know it's airborne and contagious". (Male)
"My partner is okay with it because she has TB too". (Male)
"I don't have any family except my aunt but she was scared to come and see me because she has two children". (Female)
Theme 4: Health Behavior
Sub-Theme: Behavior Modification
Clinic-based patients
"I run more. I was always a runner. The endorphins help". (Female)
"Vitamins might interact with my medications so I don't take them" (Male)
Inner-city Patients
"I eat better... although with my income, this is difficult". (Male)
"This diagnosis was a wake-up call to change my lifestyle. I now eat better and sleep lots" (Male)
"I have been drinking more booze to help manage the side effects of the medications". (Female)
"I drink bottled water and avoid tap water due to my depressed immune system" (Male)
Sub-Theme: TB Knowledge
Clinic-based patients
"It is important to be cured but you can't get it again" (Female)
"It is very important to get cured...if you aren't cured, you could die" (Male)
"Family doctors should know more about TB. They didn't know what to do with respect to breastfeeding and TB. There really needs to more 
public education" (Female)
"I don't think I have TB. My doctor told me I have it and now I have to take medications but I am not sure that I really have it" (Male).
Inner-city Patients
"Once you get TB, it's in your system" (Male)
"As long as TB can be arrested ...not necessarily cured, that would be OK (Female)"
"People should be more active in spreading the word on the street that TB is still out there...there has to be more outreach programs" (Male)Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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Behavior modification
When asked if they had done anything else beyond medi-
cations to help manage their TB, about half of the partici-
pants stated that they had done nothing in particular (n =
16). For example, a Cantonese speaking female stated "I
do nothing special as TB is very common". However, of
the 12 participants who stated that they had changed their
health behavior, seven said that they consumed a health-
ier diet, four stated that they exercised more, three took
vitamin supplements specifically to help their TB, and two
used less illicit drugs and alcohol. Representative quotes
from these participants are included in Table 4.
TB knowledge
In response to the question "do you believe that you will
be cured of TB?", most participants (n = 33) stated that
they believed that they would be eventually cured. How-
ever, some individuals believed that their TB would never
be cured ("I believe that I can keep it in remission but it
can't be cured") while others were not sure if it could be
cured. Two participants denied having TB despite being
informed by health care providers and taking medication.
There were comments regarding the participants' impres-
sions of provider knowledge of which a representative
sample have been included in Table 4.
Discussion
This qualitative study has revealed that TB has a large
impact on affected individuals' QoL through issues
related to its diagnosis, treatment, social support and
functioning, and health behavior. Specifically, we found
that the domains of QoL that were affected by TB included
those that are typically affected by most illnesses such as
physical functioning and emotional/mental well-being.
However, TB patients' social functioning was also affected
through isolation, variable social support by family and
friends, and the ability to continue with social and leisure
activities. Also, the process of getting treatment for TB
from the initial hospitalization to the daily medication
schedules adversely affected the lives of our participants,
although, almost all recognized the need for appropriate
treatment.
Although other studies [22,23] have explored patients'
attitudes and knowledge regarding TB, we identified only
one other study [24] where general health perceptions of
patients with TB were investigated. Similar to ours, this
study also involved the use of focus groups to elicit areas
of QOL affected by TB and many of their results were in
general agreement to ours. For example, as with our study,
these investigators found that physical functioning, social
functioning, and role functioning were all adversely
affected by TB. In addition, the participants reported a
wide range of psychological reactions including fear,
depression and anger. Finally, both studies found a
number of comments regarding the difficulties of treat-
ment including those related to the size, number and fre-
quency of dosing of the medications.
However, there were some important differences between
our two studies. For example, these investigators included
only 10 English speaking patients from the Baltimore city
area and 13 health care providers whereas ours included
non-English participants through the use of interpreters, a
much large sample of patients (n = 39), but no health care
providers. In addition, we included hospitalized and
ambulatory patients from both inner city and public
health clinic environments in order to assess the full spec-
trum of patients afflicted with this disease. Finally, in our
study, all patients had active TB and were receiving treat-
ment at the time of the interviews unlike the Baltimore
study who recruited patients who were already cured and
had completed treatment. We believe that our methodol-
ogy of interviewing currently afflicted patients might have
minimized recall bias although one potential advantage
of the Baltimore approach was determining long-lasting
influences of TB on patients lives (the investigators
received 17 comments in this regard). Also, the use of
health providers in the Baltimore study added an interest-
ing perspective with the provision of comments that were,
at times, in direct contrast to those stated by patients with
respect to the effects of TB on health related quality of life.
For example, most physicians underestimated the impact
that TB had on the QoL of patients assuming that, because
it was curable, its detrimental effects would be minimal.
These differences in design between the two studies might
have accounted for some different findings. For example,
the Baltimore study found that the financial well-being of
some of the participants was adversely affected through
loss of income and health care expenses whereas partici-
pants in our study did not report this issue (although this
might be attributable to the different health care environ-
ments that exist between the two countries in which the
studies were conducted or differences in employment sta-
tus between the two samples). Also, some of the male par-
ticipants in the Baltimore study reported sexual
dysfunction whereas this concern was not reported during
our interviews. Finally, patients in the Baltimore study
reported spirituality as an important domain which we
did not identify as an important theme, perhaps due to
the different ethnic/religious make-up of our sample.
One surprising aspect of our results was the negative feel-
ings associated with TB diagnosis and the initial hospital-
ization. Some participants expressed frustration with their
primary care physicians for the lack of a prompt diagnosis
or inappropriate management. There was a common per-
ception among many of the participants that health care
providers needed more extensive education regarding TB.Health and Quality of Life Outcomes 2004, 2:58 http://www.hqlo.com/content/2/1/58
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We have recently commented on the need to consider TB
as a diagnosis and in the appropriate setting, consider the
initiation of empiric TB treatment [25]. In addition, par-
ticipants complained of boredom, frustration and isola-
tion with their initial hospitalization. These modifiable
factors should be the focus on future improvements in the
diagnosis and treatment of TB.
Despite several negative comments regarding the size,
dosing schedule and adverse effects of the anti-TB medica-
tions, most patients specified that they understood the
need for treatment. As such, self-reported compliance was
very high and participants reported a variety of different
strategies to help manage adverse events. Our inner-city
participants expressed gratitude for the street nurses who
delivered their medications to them on a regular basis and
did not report the intrusiveness and imposition on life-
style that has been associated with similar programs (such
as directly observed therapy or DOT) in other studies
[24,26].
Although most comments were related to adverse impacts
of TB on QOL, some participants stated that acquiring TB
had resulted in positive health behavior modification.
Many participants took the development of TB to be a
"wake-up" call to change their lifestyle and improve their
health behavior by either eliminating or reducing drug
and alcohol intake, increasing exercise, or eating better.
These findings were also reported by the Baltimore study
group suggesting that the positive health behavior
impacts of this disease might be widespread throughout
those afflicted with TB in North America. Because many of
those afflicted with TB in North America engage in other
high-risk behaviors such as use of illicit drugs, the overall
effects of this health behavior modification might be sig-
nificant. Future studies should attempt to quantify this
impact on the downstream development of other condi-
tions. Although hospitalization for management of TB has
negative aspects we have noted that this interlude in sub-
jects with a history of substance abuse allows access to
chemical dependency treatment resources while away
from their usual chaotic environments.
Although some studies in other countries have shown that
TB can result in job loss, participants did not report that
this had occurred in our sample [27,28]. One possible rea-
son for this observation could be due to low rate of
employment in our sample with only 26% being
employed full or part-time.
Our study had some limitations. We examined a self-
selected group of TB patients who may not be representa-
tive of the entire population in Canada affected by TB. For
example, in British Columbia, foreign-born persons
account for close to 70% of all TB cases in the province.
Despite this, we feel that we were able to get a representa-
tive sample of foreign-born persons (almost 40% of our
sample was foreign born) as well as a good cross section
of marginalized inner city patients [7,29]. In fact, because
we attempted to select individuals from different socioe-
conomic groups (inner city patients vs. those voluntarily
attending a public health clinic) and from different ethnic
backgrounds (foreign-born, aboriginal-Canadian and
other Canadian), we believe that the responses that we
received are likely indicative of the areas of QoL which are
affected by TB.
Conclusion
Our study indicates that despite the ability to cure TB with
medical therapy, there still remains a sizeable impact on
the lives of afflicted patients. Since much of the current
attention on TB is spent on preventative or curative mech-
anisms such as drug therapy, the impact of this condition
on QoL is either underestimated or rarely considered. In
order to fully evaluate the outcomes that are achieved
through TB prevention and treatment, QoL of these
patients must be considered. Further studies need to build
upon these observations and instruments need to be
developed to better characterize QoL in patients with this
disease. This process will not only provide an added
parameter to evaluate the effectiveness of a given pro-
gram, but will also focus care providers to be attentive to
the non-medication aspects of TB management.
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